Cargando…
Tumor cell-intrinsic and tumor microenvironmental conditions co-determine signaling by the glycoimmune checkpoint receptor Siglec-7
Tumors create an immunosuppressive tumor microenvironment by altering protein expression, but also by changing their glycosylation status, like altered expression of sialoglycans. Sialoglycans are capped with sialic acid sugar residues and are recognized by Siglec immune receptors. Siglec-7 is an in...
Autores principales: | van Houtum, Eline J. H., Kers-Rebel, Esther D., Looman, Maaike W., Hooijberg, Erik, Büll, Christian, Granado, Daniel, Cornelissen, Lenneke A. M., Adema, Gosse J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10229725/ https://www.ncbi.nlm.nih.gov/pubmed/37253806 http://dx.doi.org/10.1007/s00018-023-04816-6 |
Ejemplares similares
-
Siglec Signaling in the Tumor Microenvironment
por: van Houtum, Eline J. H., et al.
Publicado: (2021) -
MYC-driven synthesis of Siglec ligands is a glycoimmune checkpoint
por: Smith, Benjamin A. H., et al.
Publicado: (2023) -
Expression profiling of immune inhibitory Siglecs and their ligands in patients with glioma
por: Santegoets, Kim C. M., et al.
Publicado: (2019) -
Immune Modulation Plus Tumor Ablation: Adjuvants and Antibodies to Prime and Boost Anti-Tumor Immunity In Situ
por: van den Bijgaart, Renske J. E., et al.
Publicado: (2021) -
Medawar’s PostEra: Galectins Emerged as Key Players During Fetal-Maternal Glycoimmune Adaptation
por: Menkhorst, Ellen, et al.
Publicado: (2021)